Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-012469

Options or other derivatives

  • Director acquired 53,291 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Balakrishnan Brinda Director 2021-06-14 Grant or award · Stock Option (right to buy) +53,291 53,291 D
Loading xslF345X03/wf-form4_162396231828957.xml…